|
BL631 : Bladder cancer tissue array with matched adjacent normal bladder tissue, including TNM and pathology grade, 24 cases/63 cores
Description
| Microarray Panel |
Bladder carcinoma tissue microarray with matched adjacent normal bladder tissue, containing 15 cases of transitional cell carcinoma and 3 squamous cell carcinoma, with matched adjacent normal bladder tissue (3 cores/case), 6 squamous cell carcinoma of cervix and 3 matched adjacent normal cervix tissue (1 core/block) |
| Cores |
63 |
|
| Cases |
24 |
| Row number |
7 |
| Column number |
9 |
| Core Diameter (mm) |
2 |
| Thickness (µm) |
5 |
| Quality Control |
H&E and IHC confirmed |
| Tissue Array Type |
FFPE |
| Species |
Human |
| Applications |
Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page. |
| Notes |
1. TMA slides were sectioned and stored at 4°C and may not be fresh cut, but still suitable for IHC. Please request fresh cut if experiment involves phospho-specific antibodies, RNA studies, FISH or ISH, etc. A minimum of 3 slides per TMA must be purchased to cover the cost of trimming for fresh sectioning.
2. Most TMA slides were not coated with an extra layer of paraffin (tissue cores can be easily seen on the glass). To prevent tissue detachment during antigen retrieval, unbaked slides must be baked for at least 30 to 120 minutes at 60°C. before putting into xylene for de-paraffinization. Baked slides were sent out baked for 2 hours.In the following specsheet,“*” means invalid core; “-” means no applicable or negative in IHC markers. |
Mouseover and click individual cores to view high resolution images.
Specification Sheet (Sortable), tissue IDs are available in exported Excel files.
Find overlapping cases with this tissue array:
- Product Code: BL631
- Availability: In Stock
|
Tags:
With normal control,
Diseased,
Stage (TNM),
Triplicate cores per case,
Duplicate cores per case,
Single core per case
- Malignant tumor,
- Malignant tumor (stage II),
- Malignant tumor (stage IIA),
- Malignant tumor (stage III),
- Malignant tumor (stage IIIB),
- NAT